Alternative option for common disease listed on PBS for the first time

1 October 2021 - The federal government will for the first time share the costs of an alternative treatment for two ...

Read more →

Schedule of Pharmaceutical Benefits - 1 October 2021

1 October 2021 - The October 2021 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...

Read more →

Kesimpta: game changing multiple sclerosis drug now on PBS

30 September 2021 - A new drug that promises to change the lives of thousands of Australians living with multiple sclerosis ...

Read more →

Landmark PBS listings to reduce the cost of medicines for Australians

30 September 2021 - From 1 October 2021, Australians with multiple sclerosis, multiple myeloma, macular degeneration and keratitis will have access ...

Read more →

Could discount PBS prices become ‘a thing of the past?’

27 September 2021 - The Guild has reportedly “declared war” on discounters like Chemist Warehouse, which says the suggested copay ...

Read more →

Pharmacy Guild plan to halve PBS general patient charge for prescription medicine prices

26 September 2021 - The Pharmacy Guild has declared war on discount chains like Chemist Warehouse. ...

Read more →

Thousands of Australians waiting for 'gamechanger' cystic fibrosis drug

22 September 2021 - Adelaide woman Genevieve Handley has lived with cystic fibrosis all of her life. ...

Read more →

1 October 2021 price disclosure confirmed prices

13 September 2021 - Confirmed 1 October 2021 prices resulting from the 2021 October cycle of price disclosure have now been ...

Read more →

PBAC Public Summary Documents (first time decisions not to recommend, deferrals and other matters) – May 2021 meeting

10 September 2021 - The Public Summary Documents (first time decisions not to recommend, deferrals and other matters) from the May ...

Read more →

Consumers to have more say on medicine access issues

7 September 2021 - Consumer involvement in Australia’s medicines choices has been further strengthened under a new strategic agreement Medicines ...

Read more →

MSD Australia endorses new medicines strategic agreement

8 September 2021 - MSD Australia has today welcomed the signing of a new Medicines Strategic Agreement between Medicines Australia ...

Read more →

Landmark new medicines agreements to bring significant benefits for Australian patients

7 September 2021 - Australians will have more affordable, improved and guaranteed access to medicines under landmark long-term strategic agreements between ...

Read more →

Leap forward for patients accessing medicines

7 September 2021 - Medicines Australia has secured a 5 year strategic agreement with the Federal Government, centered on earlier ...

Read more →

New treatment option for schizophrenia Reagila listed on PBS

6 September 2021 - Adults living with schizophrenia will have access to a new treatment option with Reagila (cariprazine), reimbursed ...

Read more →

Updated agenda for the November 2021 PBAC meeting

2 September 2021 - The agenda for the November 2021 PBAC meeting has been updated.  ...

Read more →